When a fluid (either gas or liquid) travels through an
hourglass-shaped pipe, there is a reduction in pressure of the fluid in
the throat of the pipe, and the velocity of the fluid increases in the
throat area, this is known as the Venturi effect. Depending on the
Venturi effect, a medical device or Venturi mask is used to deliver a
known concentration of oxygen to the patient under controlled oxygen
therapy. Entrapping the ambient air, the Venturi mask delivers constant
air flow to the patient through a small port on the mask. This type of
mask can deliver oxygen (concentration varies between 24% and 80% with
velocity 4-12 L/minute). There are several connectors of different
colors, which indicate the specific concentrations of oxygen. The
Venturi mask is less comfortable and provides less humidification
effects, as compared to nasal cannula. It is particularly effective for
patients suffering from asthma and chronic obstructive pulmonary disease
(COPD).
The global venture mask market is driven by factors such as
epidemiology of asthma and COPD patients, high diagnosis rate and
treatment rate of the asthma and COPD, and the availability of
cost-effective products. As venturi mask is less comfortable than a
nasal cannula, and it provides less humidification effects to the
patients. These technical limitations are likely to restrain the market.
On the other hand, increasing investments in R&D and continuous
innovation and developing healthcare facilities are estimated to present
significant opportunities for the global venturi mask market in the
near future.
Based on type of mask, the global venturi mask market can be segmented into adult and pediatric venturi mask. Both adult and pediatric masks are differentiated by oxygen concentration, depending upon the patient conditions. In terms of application, the global Venturi mask market can be classified into chronic obstructive pulmonary disease, asthma, respiratory distress syndrome, pneumonia, myocardial infarction, and others. In terms of end-user, the global Venturi mask market can be segregated into hospitals, out-patient clinics, and others. Venturi masks are largely consumed by hospitals; however, the usage of the venturi masks in households has been increasing significantly for the last five years.
In terms of geography, the global Venturi mask market can be
differentiated into North America, Europe, Asia Pacific, Latin America,
and Middle East & Africa. North America and Europe are projected to
hold a major share of the global venturi mask market, owing to the
higher rate of asthma and COPD patients in these regions. According to
the Centers for Disease Control and Prevention, the prevalence of adults
who are suffering from asthma is estimated to 7.6% in the U.S. in 2017,
while the estimated prevalence of COPD in the U.S. is 15.2% in the same
year. In Europe, the prevalence of asthma in adults is 8.2% and 9.4% in
children. While the estimated prevalence of COPD in Europe is 8% to 10%
in 2017. Apart from higher prevalence of asthma and COPD, other factors
that drive the North America and Europe Venturi mask market are high
rate of diagnosis and treatment rate, availability of branded and local
players, developed healthcare facilities, and technological d. According
to the Journal of Global Health, the estimated prevalence of
COPD in Southeast Asia was 10.0% in 2016. The Global Asthma Report, 2011
demonstrated that the prevalence of asthma in the South East Asia was
around 11.0% in 2016. The Asia Pacific Venturi mask market is
anticipated to expand at a significant growth rate during the forecast
period due to the significant patient pool and improving healthcare
facilities in the region. Latin America and Middle East & Africa are
anticipated to be moderate contributors to the global venturi mask
market.
Notable players operating in the global Venturi mask market include Flexicare Medical Limited, Braun & Company Ltd, Airways Corporation, Salter Labs®, Smiths Group plc., Medline Industries, Inc., and Besmed Health Business Corp.
Report Overview @ https://www.transparencymarketresearch.com/venturi-mask-market.html
Based on type of mask, the global venturi mask market can be segmented into adult and pediatric venturi mask. Both adult and pediatric masks are differentiated by oxygen concentration, depending upon the patient conditions. In terms of application, the global Venturi mask market can be classified into chronic obstructive pulmonary disease, asthma, respiratory distress syndrome, pneumonia, myocardial infarction, and others. In terms of end-user, the global Venturi mask market can be segregated into hospitals, out-patient clinics, and others. Venturi masks are largely consumed by hospitals; however, the usage of the venturi masks in households has been increasing significantly for the last five years.
Notable players operating in the global Venturi mask market include Flexicare Medical Limited, Braun & Company Ltd, Airways Corporation, Salter Labs®, Smiths Group plc., Medline Industries, Inc., and Besmed Health Business Corp.
No comments:
Post a Comment